TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.050
+0.450 (12.50%)
At close: Dec 20, 2024, 4:00 PM
4.060
+0.010 (0.25%)
After-hours: Dec 20, 2024, 6:43 PM EST
TriSalus Life Sciences Employees
TriSalus Life Sciences had 112 employees as of December 31, 2023. The number of employees increased by 37 or 49.33% compared to the previous year.
Employees
112
Change (1Y)
37
Growth (1Y)
49.33%
Revenue / Employee
$240,098
Profits / Employee
-$521,929
Market Cap
123.50M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 112 | 37 | 49.33% |
| Dec 31, 2022 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| American Well | 1,104 |
| Metagenomi | 236 |
| TELA Bio | 227 |
| Zomedica | 144 |
| Cabaletta Bio | 103 |
| Milestone Pharmaceuticals | 47 |
| Cassava Sciences | 29 |
| Eupraxia Pharmaceuticals | 29 |
TLSI News
- 5 weeks ago - TriSalus Life Sciences, Inc. (TLSI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - TriSalus Reports Q3 2024 Financial Results and Provides Business Update - Business Wire
- 5 weeks ago - TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer - Business Wire
- 6 weeks ago - TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment - Business Wire
- 7 weeks ago - TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call - Business Wire
- 2 months ago - TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit - Business Wire
- 3 months ago - TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board - Business Wire
- 3 months ago - TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System - Business Wire